oxazolidin-2-one has been researched along with Heart Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McCullough, PA; Shin, HJ | 1 |
Katsnelson, A | 1 |
Bouza, E; Giannella, M; Guinea, J; Muñoz, P; Palomo, J; Yañez, J | 1 |
Duriez, P | 1 |
1 review(s) available for oxazolidin-2-one and Heart Diseases
Article | Year |
---|---|
Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease.
Topics: Amides; Apolipoprotein A-I; Benzodiazepines; Black or African American; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Esters; Heart Diseases; Humans; Hyperlipoproteinemias; Kidney Diseases; Liver; Niacin; Observational Studies as Topic; Oxazolidinones; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Risk; Sulfhydryl Compounds; Triglycerides; White People | 2014 |
3 other study(ies) available for oxazolidin-2-one and Heart Diseases
Article | Year |
---|---|
Good news for 'good' cholesterol.
Topics: Amides; C-Reactive Protein; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Esters; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oxazolidinones; Quinolines; Sulfhydryl Compounds | 2010 |
Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid.
Topics: Acetamides; Actinomycetales Infections; Anti-Bacterial Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Bacterial; Fluconazole; Heart Diseases; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Recurrence; Rhodococcus equi; Transplantation; Treatment Outcome | 2008 |
Treating high-density lipoprotein cholesterol: a return to inhibition of cholesteryl ester transfer protein?
Topics: Anticholesteremic Agents; Atherosclerosis; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Heart Diseases; Humans; Oxazolidinones; Quinolines; Risk Factors | 2008 |